Cargando…
IgG(+) Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer
(1) Background: Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second-leading cause of cancer deaths by 2030. Imaging techniques are the standard for monitoring the therapy response in PDAC, but these techniques have considerable limits, including delayed disease progression detection...
Autores principales: | Couto, Nuno, Elzanowska, Julia, Maia, Joana, Batista, Silvia, Pereira, Catarina Esteves, Beck, Hans Christian, Carvalho, Ana Sofia, Strano Moraes, Maria Carolina, Carvalho, Carlos, Oliveira, Manuela, Matthiesen, Rune, Costa-Silva, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496671/ https://www.ncbi.nlm.nih.gov/pubmed/36139375 http://dx.doi.org/10.3390/cells11182800 |
Ejemplares similares
-
Employing Flow Cytometry to Extracellular Vesicles Sample Microvolume Analysis and Quality Control
por: Maia, Joana, et al.
Publicado: (2020) -
Transcriptome Reprogramming of CD11b(+) Bone Marrow Cells by Pancreatic Cancer Extracellular Vesicles
por: Maia, Joana, et al.
Publicado: (2020) -
Extracellular Vesicles in Diffuse Large B Cell Lymphoma: Characterization and Diagnostic Potential
por: Matthiesen, Rune, et al.
Publicado: (2022) -
Defining Optimal Conditions for Tumor Extracellular Vesicle DNA Extraction for Mutation Profiling
por: Elzanowska, Julia, et al.
Publicado: (2022) -
Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study
por: Ferreira, Bruna Velosa, et al.
Publicado: (2022)